Literature DB >> 6339742

Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.

E P Allhoff, K H Proppe, C M Chapman, C W Lin, G R Prout.   

Abstract

The peroxidase-anti-peroxidase technique was used to stain for prostate specific acid phosphatase and prostate specific antigen in 12 patients with primary tumors and in 12 patients with metastases in whom the nature of the tumor was in doubt after routine histopathological studies. Nine of the primary tumors were positive for both markers and an additional 2 tumors stained for prostate specific antigen only. Six metastatic lesions stained for both markers and a seventh for prostate specific antigen alone. Thus, 11 of 12 primary tumors and 7 of 12 metastases studied were proved to be of prostatic orgin. While the peroxidase staining was sometimes weak and uneven this method, using prostate specific antigen and prostate specific acid phosphatase, allowed for ready identification of metastases. The heterogeneity of the tumors in regard to these 2 prostate markers is demonstrated, and the value of staining for prostate specific acid phosphatase and prostate specific antigen is emphasized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339742     DOI: 10.1016/s0022-5347(17)52074-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.

Authors:  M P Gallee; E Visser-de Jong; J A van der Korput; T H van der Kwast; F J ten Kate; F H Schroeder; J Trapman
Journal:  Urol Res       Date:  1990

2.  Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.

Authors:  S Gagnon; B Têtu; J Y Dubé; R R Tremblay
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

3.  [Pathohistology and molecular genetic diagnostics in CUP syndrome].

Authors:  C Wittekind; L-C Horn
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

Review 4.  Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers.

Authors:  Sunil Kurian; Yevgeniy Grigoryev; Steve Head; Daniel Campbell; Tony Mondala; Daniel R Salomon
Journal:  Int Immunopharmacol       Date:  2007-08-09       Impact factor: 4.932

5.  Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.

Authors:  L D Papsidero; G A Croghan; J Asirwatham; J Gaeta; P Abenoza; L Englander; L Valenzuela
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

6.  A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry.

Authors:  A M Haines; S E Larkin; A P Richardson; R W Stirling; E Heyderman
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.